Clinical trial · Interventional
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
A Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in Federal Qualified Health Centers
NCT07222995CI-TRIAL-00102529recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to examine how different messages about risk of skin cancer can impact the uptake of skin cancer prevention activities.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Skin Cancer | Malignant Skin Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Precision Prevention Booklet | Behavioral | — | UNRESOLVED |
| Standard Prevention Booklet | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- Precision Prevention Intervention
- description
- Participants receive personalized skin cancer prevention materials based on MC1R genetic risk.
- interventionNames
- Behavioral: Precision Prevention Booklet
- type
- ACTIVE_COMPARATOR
- label
- Standard Prevention
- description
- Participants receive standard skin cancer prevention materials.
- interventionNames
- Behavioral: Standard Prevention Booklet
- type
- NO_INTERVENTION
- label
- Non-Intervention
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Be a patient of any race or ethnicity attending one of the six Tampa Family Health Centers. * Be 18 years of age or older. * Self-report skin cancer risk behaviors within the past 12 months, including: Intentional sun exposure (e.g., outdoor or indoor tanning) or unintentional sun exposure leading to sunburn. * Be willing to complete a baseline questionnaire and provide a saliva sample for MC1R genotyping. * Be able to provide informed consent (written or electronic). * Prefer English or Spanish for communication and study materials. Exclusion Criteria: * Do not report any skin cancer risk behaviors (i.e., no tanning or sunburning in the past 12 months). * Are unwilling or unable to complete the baseline assessment or return the saliva kit. * Decline to provide informed consent. * Are under 18 years of age.
References
Publications (1)
- DERIVEDSutton SK, Turner K, Chung-Bridges K, Vadaparampil ST, Abdulla R, Arevalo M, Avrilien N, Byrne MM, Endemano E, Hernandez JG, Hamilton JG, Lyjak E, Parrales Z, Ramos J, Torres M, White B, Hay JL, Kanetsky PA. A hybrid effectiveness-implementation trial to integrate precision skin cancer risk feedback in federally qualified health centers. Contemp Clin Trials. 2026 Aug 14:108439. doi: 10.1016/j.cct.2026.108439. Online ahead of print. PMID 42600921